Skip to content

Diagnostic and Prognostic Significance of Computerized Cytologic Morphometry of the Thyroid Neoplasm

Diagnostic and Prognostic Significance of Computerized Cytologic Morphometry of the Thyroid Neoplasm

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03105648
Enrollment
3000
Registered
2017-04-10
Start date
2016-07-01
Completion date
2026-04-20
Last updated
2021-02-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Computerized Cytomorphometry

Brief summary

The prevalence of thyroid nodule is worldwide high. About 40% of normal population has thyroid nodules and about 5% are malignancy. It is important to differentiate malignancy from benign nodules because the management is completely different. Nowadays, the gold standard is fine needle aspiration cytology (FNAC) examination. The overall sensitivity and specificity is fair (\ 90%), but still has its limitation that some results are indeterminate in about 15% of the nodules. These obstacles are especially troublesome for papillary and follicular thyroid cancer that leads to delayed diagnosis, incomplete resection, and repeated operation. Preoperative evaluation of the prognosis is extraordinary important for cancer management. However, current prognostic scoring systems is only applicable after surgery. Hence, we urgently need a better risk-stratification system for individual-tailored treatment, and genetic-based computerized morphometry study seems to be the most realistic and promising one. The goal of this study is to propose a reliable method for diagnosis and prognosis of papillary thyroid cancer and follicular thyroid cancer through analyzing cellular morphologic characteristics.

Interventions

OTHERcomputerized cytomorphometry

use computer program to analyse the characteristics of thyroid cells obtained by fine needle aspiration cytology examination

Sponsors

National Taiwan University Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
20 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* patients who previously had received thyroid fine needle aspiration cytology examination

Exclusion criteria

* patients who are younger than 20 years old

Design outcomes

Primary

MeasureTime frameDescription
cytomorphometry of the cells2016/4/20-2026/4/20cytologic characteristics of the cells

Countries

Taiwan

Contacts

Primary ContactShyang-Rong Shih, Ph.D.
srshih@ntu.edu.tw886-972653337

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026